CorrespondenceFavorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic
Keywords
COVID-19
Multiple sclerosis
Ocrelizumab
Cited by (0)
© 2020 Elsevier B.V. All rights reserved.